Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NR2E3 |
| Upstream (Parents) |
|---|
| (<<) RCAN1 → NR2E3 |
| (<<) SP140 → NR2E3 |
| (<<) GSC2 → NR2E3 |
| (<<) ARNT → NR2E3 |
| (<<) FOSL2 → NR2E3 |
| (<<) SCRT1 → NR2E3 |
| (<<) MSL3 → NR2E3 |
| (<<) HMX1 → NR2E3 |
| (<<) MLLT10 → NR2E3 |
| (<<) NFIX → NR2E3 |
| (<<) BATF3 → NR2E3 |
| (<<) HMBOX1 → NR2E3 |
| Downstream (Children) |
|---|
| NR2E3 → HOXD13 (>>) |
| NR2E3 → TBX1 (>>) |
| NR2E3 → ZNF287 (>>) |
| NR2E3 → ARNT2 (>>) |
| NR2E3 → NR2E1 (>>) |
| NR2E3 → FOXO3 (>>) |
| NR2E3 → ZNF41 (>>) |
| NR2E3 → DLX4 (>>) |
| NR2E3 → TBX4 (>>) |
| NR2E3 → HNF4G (>>) |
| NR2E3 → BATF (>>) |
